STING Agonist‐Loaded Nanoparticles Promotes Positive Regulation of Type I Interferon‐Dependent Radioimmunotherapy in Rectal Cancer
Abstract
Research context
OpenAlex topics: interferon and immune responses · Cancer Immunotherapy and Biomarkers · Cancer, Hypoxia, and Metabolism
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Radiation Oncology Fujian Cancer Hospital Fujian Medical University Fuzhou 350025 P. R. China
Department of Oncology the Second Affiliated Hospital of Nanchang University Nanchang 360000 P. R. China
Department of Clinical Oncology The University of Hong Kong‐Shenzhen Hospital Shenzhen Guangdong 518053 P. R. China
The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province Mengchao Hepatobiliary Hospital of Fujian Medical University Fuzhou 350025 P. R. China
Department of Hepatopancreatobiliary Surgery First Affiliated Hospital of Fujian Medical University Fuzhou 350004 P.R. China
School of Biomedical Engineering Shanghai Jiao Tong University Shanghai 200030 P. R. China
Department of Radiation Oncology Mengchao Hepatobiliary Hospital of Fujian Medical University Fuzhou 350025 P. R. China
CAS Key Laboratory of Design and Assembly of Functional Nanostructures Fujian Institute of Research on the Structure of Matter Chinese Academy of Sciences Fuzhou 350002 P. R. China
Mengchao Med‐X Center Fuzhou University Fuzhou 350116 P. R. China
Department of Health Science Technology and Education National Health Commission of the People's Republic of China Beijing 100088 China
State Key Laboratory of Chemical Resource Engineering College of Chemistry Beijing University of Chemical Technology Beijing 10010 P. R. China
Funding
China Postdoctoral Science Foundation